Device Week, 4 March 2022 – FDA Gets First Feedback On QMSR Draft Reg
In this episode of Device Week: A US FDA meeting on 2 March generated the first public comments the agency has heard on its proposed Quality Management System Regulation, including some industry concerns around when device makers would have to transition to the new QMSR, if finalized.
Listen to the podcast via the player below:
The archive of Medtech Insight’s Device Week, Digital Health Roundups, Speaking of Medtech and the rest of Informa Pharma Intelligence’s podcasts are available on the Informa Pharma Intelligence channel on Apple Podcasts, Google Podcasts, SoundCloud, Tune In, and Spotify Podcasts.
Medtech Insight articles addressing topics discussed in this episode: